{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T13:53:32Z","timestamp":1752674012614},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background &amp; objectives<\/jats:title>\n                <jats:p>Tumor grade determines prognosis in urothelial carcinoma. The classification of low and high grade is based on nuclear morphological features that include nuclear size, hyperchromasia and pleomorphism. These features are subjectively assessed by the pathologists and are not numerically measured, which leads to high rates of interobserver variability. The purpose of this study is to assess the value of a computer-based image analysis tool for identifying predictors of tumor grade in bladder cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Four hundred images of urothelial tumors were graded by five pathologists and two expert genitourinary pathologists using a scale of 1 (lowest grade) to 5 (highest grade). A computer algorithm was used to automatically segment the nuclei and to provide morphometric parameters for each nucleus, which were used to establish the grading algorithm. Grading algorithm was compared to pathologists\u2019 agreement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Comparison of the grading scores of the five pathologists with the expert genitourinary pathologists score showed agreement rates between 88.5% and 97.5%.The agreement rate between the two expert genitourinary pathologists was 99.5%. The quantified algorithm based conventional parameters that determine the grade (nuclear size, pleomorphism and hyperchromasia) showed\u2009&gt;\u200985% agreement with the expert genitourinary pathologists. Surprisingly, the parameter that was most associated with tumor grade was the 10th percentile of the nuclear area, and high grade was associated with lower 10th percentile nuclei, caused by the presence of more inflammatory cells in the high-grade tumors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Quantitative nuclear features could be applied to determine urothelial carcinoma grade and explore new biologically explainable parameters with better correlation to grade than those currently used.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-024-01501-5","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:01:50Z","timestamp":1717826510000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Automatic analysis of nuclear features reveals a non-tumoral predictor of tumor grade in bladder cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Ibrahim","family":"Fahoum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomo","family":"Tsuriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Rattner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asia","family":"Zubkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabab","family":"Naamneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orli","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Zemser-Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilad","family":"Gitstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Hagege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dov","family":"Hershkovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,8]]},"reference":[{"issue":"1","key":"1501_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1501_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","volume":"79","author":"RJ Sylvester","year":"2021","unstructured":"Sylvester RJ, Rodr\u00edguez O, Hern\u00e1ndez V, et al. European Association of Urology (EAU) prognostic factor risk groups for non\u2013muscle-invasive bladder Cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for Grade: an update from the EAU NMIBC guidelines Panel[Formula present. Eur Urol. 2021;79(4):480\u20138. https:\/\/doi.org\/10.1016\/j.eururo.2020.12.033.","journal-title":"Eur Urol"},{"issue":"4","key":"1501_CR3","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1097\/01.ju.0000055471.78783.ae","volume":"169","author":"MG Bol","year":"2003","unstructured":"Bol MG, Baak JP, Buhr-Wildhagen S, Kruse AJ, Kjellevold KH, Janssen EA, Mestad O\u00d8P. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol. 2003;169(4):1291\u20134.","journal-title":"J Urol"},{"issue":"1","key":"1501_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/PAS.0000000000002059","volume":"48","author":"MR Downes","year":"2024","unstructured":"Downes MR, Hartmann A, Shen S, et al. International Society of Urological Pathology (ISUP) Consensus Conference on Current issues in bladder Cancer. Working Group 1. Am J Surg Pathol. 2024;48(1):e1\u201310. https:\/\/doi.org\/10.1097\/PAS.0000000000002059.","journal-title":"Am J Surg Pathol"},{"key":"1501_CR5","doi-asserted-by":"publisher","unstructured":"van der Kwast TH, Bubendorf L, Cheng L. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. American Journal of Surgical Pathology. 2024;48(1):1\u20133. https:\/\/doi.org\/10.1097\/PAS.0000000000002066.","DOI":"10.1097\/PAS.0000000000002066"},{"issue":"1","key":"1501_CR6","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/PAS.0000000000002077","volume":"48","author":"GP Paner","year":"2024","unstructured":"Paner P GP, Kamat A, Netto GJ, et al. International Society of Urological Pathology (ISUP) Consensus Conference on Current issues in bladder Cancer. Working Group 2. Am J Surg Pathol. 2024;48(1):e11\u201323. https:\/\/doi.org\/10.1097\/PAS.0000000000002077.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1501_CR7","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.juro.2007.05.148","volume":"178","author":"HW Herr","year":"2007","unstructured":"Herr HW, Donat SM, Reuter VE. Management of low Grade Papillary bladder tumors. J Urol. 2007;178(4):1201\u20135. https:\/\/doi.org\/10.1016\/j.juro.2007.05.148.","journal-title":"J Urol"},{"issue":"3","key":"1501_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, B\u00f6hle A, Burger M, et al. EAU guidelines on non\u2013muscle-invasive Urothelial Carcinoma of the bladder: Update 2016. Eur Urol. 2017;71(3):447\u201361. https:\/\/doi.org\/10.1016\/j.eururo.2016.05.041.","journal-title":"Eur Urol"},{"key":"1501_CR9","doi-asserted-by":"crossref","unstructured":"Epstein JI, Amin MB, Reuter VRMF, The World Health Organization\/International. Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. American Journal of Surgical Pathology. 1998;22(12):1435-48.","DOI":"10.1097\/00000478-199812000-00001"},{"issue":"6","key":"1501_CR10","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.juro.2013.11.056","volume":"191","author":"ON Gofrit","year":"2014","unstructured":"Gofrit ON, Pizov G, Shapiro A, et al. Mixed high and low grade bladder tumors - are they clinically high or low grade? J Urol. 2014;191(6):1693\u20136. https:\/\/doi.org\/10.1016\/j.juro.2013.11.056.","journal-title":"J Urol"},{"issue":"1","key":"1501_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.humpath.2015.09.007","volume":"47","author":"LO Reis","year":"2016","unstructured":"Reis LO, Taheri D, Chaux A, et al. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder. Hum Pathol. 2016;47(1):20\u20135. https:\/\/doi.org\/10.1016\/j.humpath.2015.09.007.","journal-title":"Hum Pathol"},{"issue":"5","key":"1501_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/jclinpath-2021-207400","volume":"75","author":"C Coll\u00e0 Ruvolo","year":"2022","unstructured":"Coll\u00e0 Ruvolo C, W\u00fcrnschimmel C, Wenzel M, et al. Comparison between 1973 and 2004\/2016 WHO grading systems in patients with Ta Urothelial carcinoma of urinary bladder. J Clin Pathol. 2022;75(5):333\u20137. https:\/\/doi.org\/10.1136\/jclinpath-2021-207400.","journal-title":"J Clin Pathol"},{"issue":"6","key":"1501_CR13","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-019-0447-x","volume":"25","author":"D Ardila","year":"2019","unstructured":"Ardila D, Kiraly AP, Bharadwaj S, et al. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med. 2019;25(6):954\u201361. https:\/\/doi.org\/10.1038\/s41591-019-0447-x.","journal-title":"Nat Med"},{"issue":"11","key":"1501_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41571-019-0252-y.Artificial","volume":"16","author":"K Bera","year":"2019","unstructured":"Bera K, Schalper KA, Rimm DL, Velcheti V, Madabhushi A. Diagnosis and Precision Oncology. Nat Rev Clin Oncol. 2019;16(11):703\u201315. https:\/\/doi.org\/10.1038\/s41571-019-0252-y.Artificial.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"1501_CR15","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1016\/S1470-2045(19)30154-8","volume":"20","author":"MKK Niazi","year":"2019","unstructured":"Niazi MKK, Parwani AV, Gurcan MN. Digital pathology and artificial intelligence. Lancet Oncol. 2019;20(5):e253\u201361. https:\/\/doi.org\/10.1016\/S1470-2045(19)30154-8.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1501_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.acra.2019.10.001","volume":"27","author":"S Kulkarni","year":"2020","unstructured":"Kulkarni S, Seneviratne N, Baig MS, Khan AHA. Artificial Intelligence in Medicine: where are we now? Acad Radiol. 2020;27(1):62\u201370. https:\/\/doi.org\/10.1016\/j.acra.2019.10.001.","journal-title":"Acad Radiol"},{"issue":"2","key":"1501_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1470-2045(19)30739-9","volume":"21","author":"W Bulten","year":"2020","unstructured":"Bulten W, Pinckaers H, van Boven H, et al. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study. Lancet Oncol. 2020;21(2):233\u201341. https:\/\/doi.org\/10.1016\/S1470-2045(19)30739-9.","journal-title":"Lancet Oncol"},{"issue":"2","key":"1501_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1470-2045(19)30738-7","volume":"21","author":"P Str\u00f6m","year":"2020","unstructured":"Str\u00f6m P, Kartasalo K, Olsson H, et al. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. Lancet Oncol. 2020;21(2):222\u201332. https:\/\/doi.org\/10.1016\/S1470-2045(19)30738-7.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1501_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41591-021-01620-2","volume":"28","author":"W Bulten","year":"2022","unstructured":"Bulten W, Kartasalo K, Chen PHC, et al. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge. Nat Med. 2022;28(1):154\u201363. https:\/\/doi.org\/10.1038\/s41591-021-01620-2.","journal-title":"Nat Med"},{"issue":"8","key":"1501_CR20","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/s41379-021-00794-x","volume":"34","author":"S Perincheri","year":"2021","unstructured":"Perincheri S, Levi AW, Celli R, et al. An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy. Mod Pathol. 2021;34(8):1588\u201395. https:\/\/doi.org\/10.1038\/s41379-021-00794-x.","journal-title":"Mod Pathol"},{"issue":"3","key":"1501_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41379-020-0640-y","volume":"34","author":"W Bulten","year":"2021","unstructured":"Bulten W, Balkenhol M, Belinga JJA, et al. Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists. Mod Pathol. 2021;34(3):660\u201371. https:\/\/doi.org\/10.1038\/s41379-020-0640-y.","journal-title":"Mod Pathol"},{"issue":"1","key":"1501_CR22","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1038\/s41598-021-82869-y","volume":"11","author":"A Greenberg","year":"2021","unstructured":"Greenberg A, Aizic A, Zubkov A, Borsekofsky S, Hagege RR, Hershkovitz D. Automatic ganglion cell detection for improving the efficiency and accuracy of hirschprung disease diagnosis. Sci Rep. 2021;11(1):3306. https:\/\/doi.org\/10.1038\/s41598-021-82869-y.","journal-title":"Sci Rep"},{"key":"1501_CR23","doi-asserted-by":"publisher","unstructured":"Greenberg A, Samueli B, Fahoum I et al. Short training significantly improves ganglion cell detection using an algorithm-assisted Approach. Arch Pathol Lab Med. Published online 2022. https:\/\/doi.org\/10.5858\/arpa.2021-0481-oa.","DOI":"10.5858\/arpa.2021-0481-oa"},{"issue":"1","key":"1501_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13000-024-01452-x","volume":"19","author":"A Greenberg","year":"2024","unstructured":"Greenberg A, Samueli B, Farkash S, et al. Algorithm-assisted diagnosis of Hirschsprung\u2019s disease - evaluation of robustness and comparative image analysis on data from various labs and slide scanners. Diagn Pathol. 2024;19(1):26. https:\/\/doi.org\/10.1186\/s13000-024-01452-x.","journal-title":"Diagn Pathol"},{"issue":"2019","key":"1501_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.humpath.2019.04.003","volume":"89","author":"Mlisa Eich","year":"2022","unstructured":"Eich Mlisa, Chaux A, Guner G, et al. Tumor immune microenvironment in non \u2013 muscle- invasive urothelial carcinoma of the bladder \u2606, \u2606\u2606, \u2605. Hum Pathol. 2022;89(2019):24\u201332. https:\/\/doi.org\/10.1016\/j.humpath.2019.04.003.","journal-title":"Hum Pathol"},{"key":"1501_CR26","doi-asserted-by":"publisher","unstructured":"Wang B, Pan W, Yang M, et al. Programmed death ligand- 1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladder. 2019;(July. 2018;489\u201398. https:\/\/doi.org\/10.1111\/cas.13887.","DOI":"10.1111\/cas.13887"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-024-01501-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:12:26Z","timestamp":1717827146000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-024-01501-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1501"],"URL":"https:\/\/doi.org\/10.1186\/s13000-024-01501-5","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,8]]},"assertion":[{"value":"7 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data used in this study was derived from digital pathology slides identifed only by a sample number and no other identifying details. The study was approved and informed consent was waived by the local ethics committee at Tel-Aviv Sourasky medical center (ethics approval #TLV-16-660).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}